Description:

CRUS is the ticker symbol for Crispr Therapeutics AG (CRIS), but it seems there might be a mix-up as CRUS actually refers to Cavium, Inc., which was later acquired by Marvell Technology Group Ltd. Given your request pertains to CRUS on the NYSE, it appears there may be some confusion since CRUS does not currently represent an active NYSE-listed entity under its original designation. However, if we are to consider a more relevant match based on your query's context, CRISPR Therapeutics AG trades under CRS.PA on Euronext Geneva and CRSDF on OTC Markets, not NYSE. For the NYSE specifically, none of the current listings match CRUS accurately according to recent data. Therefore, the response for CRUS on NYSE is 'none'.

Data:

Yields: